eCOA User Acceptance Testing (UAT): Recommendations for Clinical Trial Success 

User Acceptance Testing (UAT) is a critical milestone and requirement in the implementation of clinical trial technology, including eCOA platforms. It’s intended to verify that the system build aligns with the study protocol, functional specifications, and real-world user expectations. 

The ICH Guideline for Good Clinical Practice E6(R3) requires UAT in order to demonstrate that the technology used to collect clinical data is functioning as intended and will support accurate and reliable data capture. 

While an important regulatory requirement, UAT can and should be more than a check-the-box exercise. It can ensure that the technology works not only according to specification and protocol, but also in the context of real-world clinical workflows. UAT testers can simulate how patients and sites complete questionnaires, how they interact with devices and technology, and how data moves through the study lifecycle. 

At uMotif, we believe that the most successful UAT processes are the result of strong and consistent collaboration between sponsors, CROs, and the eCOA provider and should be considered even at the earliest stages of study design. Based on our experience supporting sponsors and CROs, we share several recommendations for planning and conducting UATs to help guide a successful and efficient testing process. 

UAT planning: Set a solid foundation for success  

  • Avoid bias with independent UAT 

Industry best practice and guidance from organizations such as the Critical Path Institute (C-Path eCOA Consortium) calls for UAT scripts to be written by the sponsor or an independent third party, not the eCOA vendor responsible for building the system. This helps ensure the testing process remains unbiased. 

  • Think about UAT during study design 

A common misconception about UAT is that it’s confined to the final phase of study build. In reality, effective UAT preparation should begin much earlier during study design. 

uMotif embraces this approach and incorporates UAT considerations into our design workshops. These collaborative sessions are critical in building consensus around eCOA design, aligning expectations across stakeholders, and setting a solid foundation for UAT. During these sessions, uMotif works with sponsors and/or CROs to define critical elements of the eCOA solution and begin to apply a lens that will inform UAT.  

Complex studies often involve multiple workflows, for example, a patient completing a questionnaire that triggers an alert requiring action by site staff. These multi-layer workflows introduce complexity that must be carefully considered in study design and later assessed during testing. 

  • Conduct early iterative review of study functionality  

Another recommendation is to not wait until UAT to see the full study build for the first time. UAT teams should review components as they are developed. This “inspect and adapt” approach allows teams to validate assumptions early and prevents surprises when UAT begins. Ideally, script development should happen in parallel with the design workshops, allowing teams to define realistic testing scenarios while requirements are being finalized. 

  • Replicate real-world scenarios and test the entire data journey 

Effective UAT doesn’t simply check whether screens match specifications. Instead, it should simulate and test real-world clinical trial scenarios. For example, for a patient visit, the site staff completes a ClinRO and then hands the device to the patient to complete their ePRO. Testing these real-world workflows ensures the system is fit for purpose in actual study operations. 

UAT should also confirm that data flows correctly through the system from entry to end point. 

Testing should replicate the expected interactions such as: 

  • Data entry by patients or site staff 
  • Data ingestion and storage 
  • Data transfers to external systems 
  • Reporting outputs 

During testing, sponsors should verify that the data they receive matches the data entered into the system. 

  • Adopt a risk-based approach 

A risk-based approach to UAT prioritizes focus and intensity based on the potential risk a system function poses to data integrity and study compliance. 

Instead of testing every feature with the same level of intensity, more complex functionality receives deeper and more extensive testing than lower-risk features. 

A practical approach that uMotif recommends is to divide testing into two categories: 

  • Standard components, which typically include workflows such as registration processes, user login, and basic navigation. 
  • Custom workflows, which include higher-risk components such as study-specific schedules of assessments, complex questionnaires, alerts and notifications, and data reporting and transfers. 

UAT execution: Ensure effective and efficient testing  

  • Allow sufficient time to identify and prepare testers 

Sponsors should identify testers early and ensure they understand: 

  • The system environment
  • Their testing responsibilities 
  • Testing timelines 

Testers should also receive training on the platform and testing process before UAT starts. Knowledge of the system and scripts allows them to focus on validating workflows rather than learning how to navigate the interface. 

  • Maintain open communication during testing 

Strong communication helps keep UAT running smoothly. During testing, this should include regular check in meetings, an open help line to the vendor, and drop-in clinics for testers. The vendor also should convene a cross-functional team, including developers and technical support, to address issues promptly as testers identify them. This accelerates issue resolution so testing can continue without delay and not impact go-live timelines.   

Preparing for go-live and managing post-live changes 

As UAT concludes, the focus shifts to preparing the study for launch. During this phase, the eCOA vendor should review testing results and establish a clear plan for future releases, if needed, and their timing. 

The final step is formal acceptance and sign-off of UAT documentation and results. It’s important to ensure that all stakeholders clearly understand who has responsibility for approving the UAT. Confusion around sign-off authority can create avoidable delays. 

It’s also important to remember that UAT doesn’t end at go-live. 

Any changes made to the study after launch, such as protocol amendments, new questionnaires, or workflow adjustments should go through the same UAT process. 

At uMotif, we believe that successful UAT starts with collaboration and transparency from day one. By working closely with sponsors and/or CROs throughout design, build, and testing, we help ensure that eCOA instruments and workflows are not only compliant, but also intuitive, reliable, and ready for use.